Imidafenacin: A Key Pharmaceutical Intermediate for Overactive Bladder Treatment
Unlock advanced therapeutic solutions with high-purity Imidafenacin, a vital component for treating overactive bladder.
Get a Quote & SampleProduct Core Value
Imidafenacin
Imidafenacin (CAS 170105-16-5) stands out as a critical pharmaceutical intermediate, essential for the development of medications targeting overactive bladder (OAB). Its pharmacological action as a selective muscarinic M1 and M3 receptor antagonist helps to alleviate symptoms associated with detrusor muscle overactivity. The rigorous synthesis process ensures a high purity level, making it a reliable choice for pharmaceutical manufacturers seeking effective bladder control solutions.
- Discover the efficacy of Imidafenacin as a pharmaceutical intermediate in our detailed guide.
- Understand the unique muscarinic receptor antagonist properties vital for overactive bladder treatment.
- Explore the chemical synthesis process of Imidafenacin, ensuring high quality for your pharmaceutical needs.
- Access a broad network of suppliers for CAS 170105-16-5 raw material to secure your supply chain.
Product Advantages
High Purity and Efficacy
Achieve superior therapeutic outcomes with our high-purity Imidafenacin, a key pharmaceutical intermediate that guarantees efficacy in overactive bladder treatments.
Targeted Muscarinic Receptor Action
Leverage the specific muscarinic receptor antagonist capabilities of Imidafenacin for precise bladder control and improved patient quality of life.
Reliable Supply Chain
Ensure consistent availability of Imidafenacin, a crucial raw material for your manufacturing processes, through a robust global supplier network.
Key Applications
Pharmaceutical Synthesis
Utilize Imidafenacin as a fundamental building block in the synthesis of advanced pharmaceutical compounds, particularly those aimed at urological conditions.
Overactive Bladder Treatment
Formulate effective medications for overactive bladder using Imidafenacin, a proven muscarinic antagonist that targets the root causes of frequent urination.
Drug Development
Advance your drug development pipeline with Imidafenacin, a well-characterized intermediate that aids in creating innovative treatments for bladder dysfunction.
Medical Research
Support groundbreaking medical research into bladder control mechanisms and pharmacological interventions with reliable supplies of Imidafenacin.